The Ohio State University named Peter Mohler vice president for research. Mohler had been serving as interim vice president since spring 2021. In this role, he will continue to lead strategy and efforts to grow Ohio State’s research and creative expression enterprise, and oversee research operations, sponsored programs and research compliance while providing strategic direction and oversight for large-scale, interdisciplinary research centers and institutes. He will also continue his role as chief scientific officer for the Wexner Medical Center at Ohio State.
Mohler has been at Ohio State since 2011 when he was recruited to Columbus as the director of Dorothy M. Davis Heart and Lung Research Institute and subsequently served as Chair of the Department of Physiology and Cell Biology in the College of Medicine. Mohler also has previously served as vice dean of research in the College of Medicine.
The Office of Research is a part of the Enterprise for Research, Innovation and Knowledge (ERIK). ERIK focuses on expanding the university’s cutting-edge research, creative expression and scholarship, stimulating technology commercialization and entrepreneurship, building strategic partnerships and developing the innovation district.
“Dr. Mohler is a proven research leader who understands that our strength lies in the extraordinary breadth and scale of our research and creative expression efforts at Ohio State,” said Grace Wang, executive vice president for the Enterprise for Research, Innovation and Knowledge. “He and his team will play a critical role in our efforts to double research expenditures over the next decade.
Mohler has more than 250 publications including manuscripts in Nature, Cell, Journal of Clinical Investigation, Circulation, Circulation Research, Nature Medicine, Journal of Cell Biology, and PNAS. His research focuses on uncovering the mechanisms underlying abnormal heart rhythms and heart failure in children and young adults with the goal of designing new diagnostics and therapies in individuals and populations.
Mohler has received multiple awards, including being named a Pew Scholar an Outstanding Investigator of the American Heart Association. In 2015 he received the inaugural College of Medicine Distinguished Mentor Award. He recently served on the Program Project Grant (P01) Parent committee for the National Heart Lung and Blood Institute. Dr. Mohler was named an inaugural NIH National Heart Lung and Blood Institute Outstanding Investigator (R35 Award) and leads large program grants funded by the American Heart Association and the LeDucq Foundation.
Mohler received a bachelor’s in biology from Wake Forest University, his doctorate in cell and molecular physiology from the University of North Carolina at Chapel Hill and performed a postdoctoral fellowship in the Howard Hughes Medical Institute at Duke University Medical Center.
Earlier this week Ohio State announced that expenditures for the 2021 fiscal year were $1.2 billion. The analysis is part of the university’s Office of Research submission to the National Science Foundation’s Higher Education Research and Development (HERD) Survey.
Mohler in the news
- Ohio State College of Medicine sets new NIH research funding record
- New variant of COVID-19 virus discovered in Columbus
- Ohio State to study impact of COVID-19 in first responders with $10 million grant
- College of Medicine creates new center to spark medical research, innovation